SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 65 filers reported holding SUTRO BIOPHARMA INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $982,284 | -13.0% | 283,079 | +16.6% | 0.31% | -1.0% |
| Q2 2023 | $1,128,922 | +188.5% | 242,779 | +186.6% | 0.31% | +164.1% |
| Q1 2023 | $391,314 | -13.2% | 84,700 | +4.3% | 0.12% | -3.3% |
| Q3 2022 | $451,000 | +2.3% | 81,200 | -4.1% | 0.12% | +0.8% |
| Q2 2022 | $441,000 | -36.6% | 84,700 | 0.0% | 0.12% | -33.7% |
| Q1 2022 | $696,000 | +3.9% | 84,700 | +88.2% | 0.18% | +7.7% |
| Q4 2021 | $670,000 | -58.3% | 45,000 | -47.1% | 0.17% | -60.6% |
| Q3 2021 | $1,606,000 | +1.6% | 85,000 | 0.0% | 0.43% | +29.1% |
| Q2 2021 | $1,580,000 | -18.3% | 85,000 | 0.0% | 0.33% | -28.1% |
| Q1 2021 | $1,935,000 | +4.9% | 85,000 | 0.0% | 0.46% | -16.4% |
| Q4 2020 | $1,845,000 | +54.4% | 85,000 | -28.5% | 0.55% | +41.5% |
| Q3 2020 | $1,195,000 | +44.7% | 118,940 | +11.7% | 0.39% | +63.0% |
| Q2 2020 | $826,000 | +102.5% | 106,444 | +166.1% | 0.24% | +40.0% |
| Q1 2020 | $408,000 | -7.3% | 40,000 | 0.0% | 0.17% | +12.6% |
| Q4 2019 | $440,000 | +20.9% | 40,000 | 0.0% | 0.15% | +10.2% |
| Q3 2019 | $364,000 | +1.7% | 40,000 | +27.0% | 0.14% | +1.5% |
| Q2 2019 | $358,000 | -0.3% | 31,494 | 0.0% | 0.14% | -12.9% |
| Q1 2019 | $359,000 | +26.4% | 31,494 | 0.0% | 0.16% | +9.9% |
| Q4 2018 | $284,000 | -31.1% | 31,494 | +14.5% | 0.14% | -16.6% |
| Q3 2018 | $412,000 | – | 27,494 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,675,579 | $13,773,000 | 3.47% |
| AJU IB Investment Co., Ltd. | 175,000 | $1,439,000 | 2.22% |
| Frazier Life Sciences Management, L.P. | 1,776,479 | $14,603,000 | 1.24% |
| First Light Asset Management, LLC | 1,672,497 | $13,748,000 | 1.21% |
| BVF INC/IL | 3,447,946 | $28,342,000 | 1.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,732,400 | $30,680,000 | 0.94% |
| Endurant Capital Management LP | 296,508 | $2,437,000 | 0.64% |
| Parkman Healthcare Partners LLC | 199,846 | $1,643,000 | 0.48% |
| Eventide Asset Management | 2,708,975 | $22,268,000 | 0.35% |
| Lombard Odier Asset Management (Switzerland) SA | 391,024 | $3,214,000 | 0.25% |